谷歌浏览器插件
订阅小程序
在清言上使用

Supplementary Figures 1 Through 5 and Supplementary Tables 1 Through 3 from Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients is Determined by a Four-Parameter Tumor Immune Signature

crossref(2023)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要